{"id":"W4387812289","doi":"10.1016/j.annonc.2023.09.1542","title":"40P Bioinformatic evaluation of the transcriptomic and immunologic profile of prostate tumors with high expression of kallikrein-2","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Genentech; Servier; European Society for Medical Oncology; CRIS Cancer Foundation; Astellas Pharma; Sierra Oncology; Incyte; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Eisai; Sociedad Española de Oncología Médica; BeiGene; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; PharmaMar; Celgene","keywords":"Cancer research; CD8; Medicine; Prostate cancer; Cytotoxic T cell; T cell; Population; Immune system; Transcriptome; Cancer; Immunology; Biology; Internal medicine; Gene expression; Gene; In vitro; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002573816,0.000524953,0.0004546012,0.001106208,0.0007236387,0.0006244396,0.0002497142,0.0005571552,0.007891439],"category_scores_gemma":[0.0005050267,0.0001906002,0.0007262722,0.001114304,0.0002553723,0.0002355572,0.0004522434,0.0005951237,0.002225196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003249401,"about_ca_system_score_gemma":0.0005174527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001190759,"about_ca_topic_score_gemma":0.002253207,"domain_scores_codex":[0.9997359,0.0000208698,0.00001453117,0.00009266453,0.00007457344,0.00006138757],"domain_scores_gemma":[0.9997513,0.00008452431,0.00005493224,0.00001805867,0.00004371581,0.00004746519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001522096,0.0001929098,0.03108472,0.000894019,0.0002100011,0.001961822,0.0003719933,0.001764174,0.9104266,0.0009660688,0.009806306,0.04079925],"study_design_scores_gemma":[0.0002609777,0.001000838,0.616936,0.0003528665,0.0008054437,0.007433595,0.001399525,0.04477574,0.2128219,0.004806195,0.1091943,0.0002125446],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8736355,0.003398932,0.01911831,0.001313275,0.0004446645,0.0001379999,0.08903188,0.002766002,0.01015344],"genre_scores_gemma":[0.8812278,0.001271264,0.03097218,0.00105185,0.0001456535,0.0002519303,0.07750051,0.0007443826,0.006834446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007891439,"threshold_uncertainty_score":0.02639949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04737649435270452,"score_gpt":0.3132899540077236,"score_spread":0.2659134596550191,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}